News
-
-
PRESS RELEASE
Zeus North America Mining Corp. Applauds the Executive Order to Accelerate Critical Mineral Production, including Copper, in the USA
United States President Donald J. Trump signs Executive Order to accelerate domestic copper production under the Defense Production Act, impacting companies like Zeus North America Mining Corp -
-
PRESS RELEASE
GoldenPeaks Capital starts production at its newest solar power plant near Bodroghalom, Hungary
GoldenPeaks Capital starts production at its newest 64.56 MW solar power plant in Bodroghalom, Hungary, delivering 94.6 GWh/year of clean energy, contributing to decarbonization efforts in the region -
PRESS RELEASE
JOST slightly increases earnings after taxes in financial year 2024 and proposes a dividend of EUR 1.50 per share
JOST Werke SE slightly increases earnings after taxes in financial year 2024, achieves sales forecast, and proposes EUR 1.50 dividend per share. Full details in press release -
REGULATED PRESS RELEASE
Résultats annuels 2024 - ANR par action : + 2,42 % à 91,52 € - Capitaux propres consolidés : 696 M€
L'IDI annonce des résultats annuels solides pour 2024 avec une croissance de l'ANR par action de +2,42%, des capitaux propres de 696M€ et un dividende proposé de 4,20€/action. Forte capacité d'investissement de 346M€ au 25 mars 2025 -
-
PRESS RELEASE
Tocvan Core Drilling Discovers Highest Gold-Grade Interval Ever Outside of the Main Zone, 300 meters East Returns 21.6 g/t Gold and 209 g/t Ag Over 3.0 meters within 64.9 meters of 1.2 g/t Gold
Tocvan Ventures Corp. announces high-grade gold-silver discovery 300m east of Main Zone in Gran Pilar Project, Sonora, Mexico, ideal for early mine development. Results include intervals of 21.6 g/t Au, 209 g/t Ag and 2.8 g/t Au, 38 g/t Ag, suggesting significant potential -
REGULATED PRESS RELEASE
Biophytis annonce le succès d'un placement privé d'environ 2,6 millions d'euros
Biophytis annonce le succès d'un placement privé d'environ 2,6 millions d'euros. Augmentation de capital pour accélérer le développement de traitements et soutenir les activités de recherche et de partenariats -
